TickerStat.comwe like data

Regeneron Pharmaceuticals, Inc. (REGN)

Price$750.51Cached quote
REGNNasdaq
Loading local price history

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

18 annual periodsNewest to oldest
202520242023202220212020201920182017201620152014201320122011201020092008
Revenue$14.34B$14.20B$13.12B$12.17B$16.07B$8.50B$6.56B$5.15B$5.87B$4.86B$4.10B$2.82B$2.10B$1.38B$445.8M$459.1M$379.3M$238.5M
Gross profit$12.24B$12.23B$11.30B$10.61B——$6.15B$4.91B$5.67B$4.67B$3.86B$2.69B$1.99B$1.29B$441.6M$457.0M$377.6M$237.5M
Gross margin85.35%86.13%86.16%87.18%——93.86%95.38%96.55%96.00%94.11%95.42%94.39%93.91%99.05%99.54%99.56%99.61%
Research & development$5.85B$5.13B$4.44B$3.59B$2.86B$2.65B$2.45B$1.47B$2.08B$2.05B$1.62B$1.27B$859.9M$625.6M$529.5M$489.3M$398.8M$274.9M
Operating expenses$10.77B$10.21B$9.07B$7.43B$7.12B$4.92B$4.35B$2.61B$3.79B$3.53B$2.85B$2.00B$1.36B$920.8M$651.0M$556.5M$453.4M$324.7M
Operating income$3.58B$3.99B$4.05B$4.74B$8.95B$3.58B$2.21B$2.53B$2.08B$1.33B$1.25B$823.9M$743.0M$457.7M−$205.2M−$97.5M−$74.1M−$86.2M
Operating margin24.95%28.10%30.85%38.93%55.67%42.09%33.70%49.25%35.41%27.38%30.51%29.22%35.30%33.20%−46.02%−21.23%−19.54%−36.17%
EBITDA$4.12B$4.47B$4.47B$5.08B$9.23B$3.81B$2.42B$2.68B$2.23B$1.44B$1.33B$876.6M$784.3M$494.7M−$174.1M−$77.8M−$59.9M−$75.0M
EBITDA margin28.74%31.50%34.06%41.73%57.45%44.87%36.91%52.13%37.89%29.53%32.33%31.09%37.26%35.88%−39.05%−16.94%−15.79%−31.44%
Net income$4.50B$4.41B$3.95B$4.34B$8.08B$3.51B$2.12B$2.44B$1.20B$895.5M$636.1M$338.1M$413.7M$750.3M−$221.8M−$104.5M−$67.8M−$79.1M
Net profit margin31.41%31.07%30.14%35.64%50.25%41.35%32.26%47.50%20.41%18.42%15.50%11.99%19.66%54.43%−49.74%−22.76%−17.88%−33.18%
Basic EPSper basic share$43.07$40.90$37.05$40.51$76.40$32.65$19.38$22.65$11.27$8.55$6.17$3.36$4.23$7.92-$2.45-$1.26-$0.85-$1.00
Diluted EPSper diluted share$41.48$38.34$34.77$38.22$71.97$30.52$18.46$21.29$10.34$7.70$5.52$2.98$3.72$6.75-$2.45-$1.26-$0.85-$1.00
Review official source filings ↗

Owners

Reported shareholders

Reference date Jun 30, 2026

Reported holdings Number of shares

View holders
Top 20 reported holders of REGN
HolderShares held
BlackRock, Inc.
9.11M
VANGUARD CAPITAL MANAGEMENT LLC
6.63M
Dodge & Cox
4.87M
STATE STREET CORP
4.83M
Invesco Ltd.
3.94M
JPMORGAN CHASE & CO
3.77M
VANGUARD PORTFOLIO MANAGEMENT LLC
3.18M
FRANKLIN RESOURCES INC
2.77M
GEODE CAPITAL MANAGEMENT, LLC
2.63M
Nuveen, LLC
2.02M
LOOMIS SAYLES & CO L P
1.86M
PRICE T ROWE ASSOCIATES INC /MD/
1.53M
MORGAN STANLEY
1.4M
BANK OF AMERICA CORP /DE/
1.29M
WELLINGTON MANAGEMENT GROUP LLP
1.27M
NORGES BANK
1.17M
GOLDMAN SACHS GROUP INC
1.16M
AQR CAPITAL MANAGEMENT LLC
1.13M
Amundi
1.01M
NORTHERN TRUST CORP
916.47K

Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.

Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)215$52.04M disclosed value
215 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
May 1, 2026Form 4 · 10b5-1RYAN ARTHUR FDirectorSellCommon Stock2$714.13$1.4K17.5K
May 1, 2026Form 4 · 10b5-1RYAN ARTHUR FDirectorSellCommon Stock1$712.09$712.0917.5K
May 1, 2026Form 4 · 10b5-1RYAN ARTHUR FDirectorSellCommon Stock5$711.49$3.6K17.5K
May 1, 2026Form 4 · 10b5-1RYAN ARTHUR FDirectorSellCommon Stock2$710.87$1.4K17.5K
May 1, 2026Form 4 · 10b5-1RYAN ARTHUR FDirectorSellCommon Stock6$709.45$4.3K17.5K
Review ownership filings at SEC.gov ↗

Community posts

View community

It’s quiet here.

No posts about REGN yet. Start the conversation.

Write the first post